Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF)
Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF)
Active, not recruiting · NCT03645824 · Registry updated 2022-08-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF) | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Active, not recruiting | Phase 2 | 2022-08-22 | NCT03645824 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CTI BioPharma | 2 |
| Dutch Cancer Society | 41 |
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 27 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BE-Antwerpen-ZNASTUIVENBERG | Antwerp | Belgium | 8 |
| BE-Gent-UZGENT | Ghent | Belgium | 7 |
| BE-Leuven-UZLEUVEN | Leuven | Belgium | 10 |
| BE-Roeselare-AZDELTA | Roeselare | Belgium | 7 |
| NL-Amsterdam-AMC | Amsterdam | Netherlands | 10 |
| NL-Amsterdam-VUMC | Amsterdam | Netherlands | 10 |
| NL-Groningen-UMCG | Groningen | Netherlands | 17 |
| NL-Maastricht-MUMC | Maastricht | Netherlands | 13 |
| NL-Nijmegen-RADBOUDUMC | Nijmegen | Netherlands | 11 |
| NL-Rotterdam-EMCDANIEL | Rotterdam | Netherlands | 1 |
| NL-Rotterdam-ERASMUSMC | Rotterdam | Netherlands | 14 |
| NL-Utrecht-UMCUTRECHT | Utrecht | Netherlands | 16 |